Skip to content

Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital

Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06449794
Enrollment
50
Registered
2024-06-10
Start date
2024-06-01
Completion date
2025-06-01
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus

Brief summary

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease involving multiple organs, characterized by the production of autoantibodies and the development of tissue injury. The etiology of SLE is partially known, involving multiple genetic and environmental factors. As many as 50% of patients with SLE have neurological involvement during the course of their disease. Approximately 40% of neuropsychiatric SLE (NPSLE) cases are a consequence of the disease itself; other causes of NPSLE are infections, metabolic disorders, and side effects of drugs. The American College of Rheumatology identified 19 neuropsychiatric syndromes in SLE patients that can be divided into central and peripheral nervous system manifestations. Although this classification includes syndromes with no clear pathophysiological mechanism and is not specific for neuropsychiatric events caused exclusively by SLE, it helps the physician to recognize any neurological involvement . The most common clinical manifestations of juvenile neuropsychiatric SLE (NPSLE) are headache, cognitive dysfunction, mood disturbances and seizures. The pathophysiology of juvenile NPSLE is not yet fully known, but immunological and inflammatory factors, such as autoantibodies, cytokine and prothrombotic states are widely described . The of autoantibodies in the onset of specific clinical manifestations has also been recognized. Juvenile NPSLE manifestations are often difficult to diagnose (. Nineteen neuropsychiatric syndromes have been identified associated with SLE, can be divided into central and peripheral manifestations.

Interventions

DIAGNOSTIC_TESTAnti Phospholipid antibodies

diagnosis of SLE

RADIATIONEEG

EEG for Cases with seizures.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum

Inclusion criteria

* The study aims to include all children fulfilling the diagnostic criteria of SLE (The European League Against Rheumatism and The American College of Rheumatology (9)) attending to pediatric rheumatology and immunology clinic at Sohag University Hospitals during the study period.

Exclusion criteria

* Children with other rheumatological disorders.; Neonates (infants \> 1 month) Children with other neuropsychiatric disorders not attributed to SLE ( e.g. infection, metabolic disorders or side effects of drugs).

Design outcomes

Primary

MeasureTime frameDescription
detect the clinical spectrum of Neuropsycatric disorders in Children with SLE1 yearthe diagnostic criteria of SLE (The European League Against Rheumatism and The American College of Rheumatology

Countries

Egypt

Contacts

Primary ContactAmira M Mahmoud, resident
amerah.mahmoud@med.sohag.edu.eg01098129862
Backup ContactMontaser M Mohammed, assistant professor
01026372799

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026